0001140361-19-018081.txt : 20191007 0001140361-19-018081.hdr.sgml : 20191007 20191007192554 ACCESSION NUMBER: 0001140361-19-018081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191007 DATE AS OF CHANGE: 20191007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Magni Guido CENTRAL INDEX KEY: 0001437150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 191141677 MAIL ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 form4.xml FORM 4 X0306 4 2019-10-07 0001781983 Aprea Therapeutics, Inc. APRE 0001437150 Magni Guido 535 BOYLSTON STREET BOSTON MA 02116 true Common Stock 2019-10-07 4 P 0 6500 15 A 6500 D /s/ Scott M. Coiante, attorney-in-fact 2019-10-07